Skip to main content
Harriet Richardson BSc, MSc, PhD
 Harriet Richardson
Investigator, CCTG and CCE divisions
Contact Info
613-533-6000 x78958

Faculty Bio

  • Member, Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University
  • Associate Professor, Department of Public Health Sciences
  • Cross Appointment with Canadian Cancer Trials Group (CCTG) as Project Coordinator


Dr. Richardson is an epidemiologist and professor in the Department of Public Health Sciences at Queen's University. Dr. Richardson, who bridges the Canadian Cancer Trials Group (CCTG) and the Division of Cancer Care and Epidemiology, has focussed on breast cancer prevention in the context of clinical trials (e.g. evaluating anti-estrogen agents and their effect on breast cancer incidence and/or mammographic density). She is the senior author of a ground-breaking paper published in the New England Journal of Medicine in June 2011 relating to Exemestane for breast cancer prevention in postmenopausal women.  Additional studies evaluate how aromatase inhibitors affect bone strength and quality. Her research also involves tissue and blood banking for future biomarker development projects, evaluating quality of life data from clinical trials, and evaluating family physician knowledge and practice patterns in breast cancer prevention.

Current Interests

  • Cancer prevention trial methodology
  • Describing (for the purpose of improving) family physicians' use of primary prevention strategies
  • Quality of life data from clinical trials


Dr. Richardson's publications are available on PubMed.